Vnitr Lek 2010, 56(6):557-569

Sepsis and the septic shock in oncological or other immunocompromised patients

M. Navrátil*, M. Tomíška, Z. Kořístek, J. Vorlíček, J. Mayer
Interní hematoonkologická klinika Lékařské fakulty MU a FN Brno, pracoviště Bohunice, přednosta prof. MUDr. Jiří Vorlíček, CSc.

Sepsis and the septic shock and the up to date knowledge about them represent a marked drifting for diagnostics and the treatment of this complications. Their application in patients with the oncological disease or the other immunocompromised patients represents further extension in the specific group of patients with several unique properties. In despite of the improving results in the oncological treatment there are only few reports in literature about this group of patients and this one is steadily growing due to the progressive improving of the supportive care in oncology. This group of patients with the febrile neutropenia and the sepsis (the most frequent complication) request the special focus of general practitioners and the internists because these ones are with these patients in contact as a first. They have to master the basal image about the specialties of this patient group. In our article we analyze this group of patients with focus on antibiotics in febrilie neutropenia and sepsis and on the other supportive care in the immunocopromised patients.

Keywords: sepsis; septic shock; febrilie neutropenia; immunocompromised patient

Received: May 7, 2010; Published: June 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Navrátil M, Tomíška M, Kořístek Z, Vorlíček J, Mayer J. Sepsis and the septic shock in oncological or other immunocompromised patients. Vnitr Lek. 2010;56(6):557-569.
Download citation

References

  1. Antonelli M, Azoulay E, Bonten M et al. Year in review in Intensive Care Medicine, 2008: I. Brain injury and neurology, renal failure and endocrinology, metabolism and nutrition, sepsis, infections and pneumonia. Intensive Care Med 2009; 35: 30-44. Go to original source... Go to PubMed...
  2. Antonelli M, Azoulay E, Bonten M et al. Year in review in Intensive Care Medicine, 2007. II. Haemodynamics, pneumonia, infections and sepsis, invasive and non-invasive mechanical ventilation, acute respiratory distress syndrome. Intensive Care Med 2008; 34: 405-422. Go to original source... Go to PubMed...
  3. Antonelli M, Azoulay E, Bonten M et al. Year in review in Intensive Care Medicine 2009: I. Pneumonia and infections, sepsis, outcome, acute renal failure and acid base, nutrition and glycaemic control. Intensive Care Med 2010; 36: 196-209. Go to original source... Go to PubMed...
  4. Bagshaw SM, Bellomo R. Early diagnosis of acute kidney injury. Curr Opin Crit Care 2007; 13: 638-644. Go to original source... Go to PubMed...
  5. Bagshaw SM, Bellomo R. The influence of volume management on outcome. Curr Opin Crit Care 2007; 13: 541-548. Go to original source... Go to PubMed...
  6. Boyd JH, Walley KR. Is there a role for sodium bicarbonate in treating lactic acidosis from shock? Curr Opin Crit Care 2008; 14: 379-383. Go to original source... Go to PubMed...
  7. Camporota L, Wyncoll D. Practical aspects of treatment with drotrecogin alfa (activated). Crit Care 2007; 11 (Suppl 5): S7. Go to original source... Go to PubMed...
  8. Canabal JM, Kramer DJ. Management of sepsis in patients with liver failure. Curr Opin Crit Care 2008; 14: 189-197. Go to original source... Go to PubMed...
  9. Casserly B, Read R, Levy MM. Hemodynamic monitoring in sepsis. Crit Care Clin 2009; 25: 803-823. Go to original source... Go to PubMed...
  10. Zanotti Cavazzoni SL, Dellinger RP. Hemodynamic optimization of sepsis-induced tissue hypoperfusion. Crit Care 2006; 10 (Suppl 3): S2. Go to original source... Go to PubMed...
  11. Cheng AC, Stephens DP, Currie BJ. Granulocyte-colony stimulating factor (G-CSF) as an adjunct to antibiotics in the treatment of pneumonia in adults. Cochrane Database Syst Rev 2007; 2: CD004400. Go to original source... Go to PubMed...
  12. Christaki E, Opal SM. Is the mortality rate for septic shock really decreasing? Curr Opin Crit Care 2008; 14: 580-586. Go to original source... Go to PubMed...
  13. Cinel I, Opal SM. Molecular biology of inflammation and sepsis: a primer. Crit Care Med 2009; 37: 291-304. Go to original source... Go to PubMed...
  14. Claessens YE, Dhainaut JF. Diagnosis and treatment of severe sepsis. Crit Care 2007; 11 (Suppl 5): S2. Go to original source... Go to PubMed...
  15. Dellinger RP, Levy MM, Carlet JM et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 2008; 34: 17-60. Go to original source... Go to PubMed...
  16. Dellinger RP, Levy MM, Carlet JM et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36: 296-327. Go to original source... Go to PubMed...
  17. Doig GS, Heighes PT, Simpson F et al. Early enteral nutrition, provided within 24 h of injury or intensive care unit admission, significantly reduces mortality in critically ill patients: a meta-analysis of randomised controlled trials. Intensive Care Med 2009; 35: 2018-2027. Go to original source... Go to PubMed...
  18. Downar J, Lapinsky SE. Pro/con debate: should synthetic colloids be used in patients with septic shock? Crit Care 2009; 13: 203. Go to original source... Go to PubMed...
  19. Fortin CF, McDonald PP, Fülöp T et al. Sepsis, leukocytes, and nitric oxide (NO): an intricate affair. Shock 2010; 33: 344-352. Go to original source... Go to PubMed...
  20. Frank AJ, Thompson BT. Pharmacological treatments for acute respiratory distress syndrome. Curr Opin Crit Care 2010; 16: 62-68. Go to original source... Go to PubMed...
  21. Funk D, Sebat F, Kumar A. A systems approach to the early recognition and rapid administration of best practice therapy in sepsis and septic shock. Curr Opin Crit Care 2009; 15: 301-307. Go to original source... Go to PubMed...
  22. Gao H, Evans T W, Finney SJ. Bench-to-bedside review: Sepsis, severe sepsis and septic shock - does the nature of the infecting organism matter? Crit Care 2008; 12: 213. Go to original source... Go to PubMed...
  23. Gottschlich B, Koch T. Nutritional support of intensive care patients. Anasthesiol Intensiv Med 2008; 49: 318.
  24. Groeneveld AB, Molenaar N, Beishuizen B. Should we abandon corticosteroids during septic shock? No. Curr Opin Crit Care 2008; 14: 384-389. Go to original source... Go to PubMed...
  25. Hausfater P. Procalcitonin measurement in adult clinical practice. Rev Med Interne 2007; 28: 296-305. Go to original source... Go to PubMed...
  26. Heller AR, Ragaller M. Intestinal malfunction in the ICU. Anasthesiol Intensiv Med 2008; 49: 20.
  27. Hollenberg SM. Inotrope and vasopressor therapy of septic shock. Crit Care Clin 2009; 25: 781-802. Go to original source... Go to PubMed...
  28. Hollenberg SM, Cinel I. Bench-to-bedside review: nitric oxide in critical illness - update 2008. Critl Care 2009; 13: 218. Go to original source... Go to PubMed...
  29. Holmes CL, Walley KR. Vasoactive drugs for vasodilatory shock in ICU. Curr Opin Crit Care 2009; 15: 398-402. Go to original source... Go to PubMed...
  30. Khan S, Trof RJ, Groeneveld AB. Transpulmonary dilution-derived extravascular lung water as a measure of lung edema. Curr Opin Crit Care 2007; 13: 303-307. Go to original source... Go to PubMed...
  31. Klastersky J. Empirical treatment of sepsis in neutropenic patients. Hosp Med 2001; 62: 101-103. Go to original source... Go to PubMed...
  32. Klastersky J, Paesmans M. Risk-adapted strategy for the management of febrile neutropenia in cancer patients. Support Care Cancer 2007; 15: 477-482. Go to original source... Go to PubMed...
  33. Kollef MH, Micek ST. Using protocols to improve patient outcomes in the intensive care unit: focus on mechanical ventilation and sepsis. Semin Respir Crit Care Med 2010; 31: 19-30. Go to original source... Go to PubMed...
  34. Lange M, Ertmer C, Westphal M. Vasopressin vs. terlipressin in the treatment of cardiovascular failure in sepsis. Intensive Care Med 2008; 34: 821-832. Go to original source... Go to PubMed...
  35. Laterre PF. Clinical trials in severe sepsis with drotrecogin alfa (activated). Crit Care 2007; 11 (Suppl 5): S5. Go to original source... Go to PubMed...
  36. Leaver SK, Finney SJ, Burke-Gaffney A et al. Sepsis since the discovery of Toll-like receptors: disease concepts and therapeutic opportunities. Crit Care Med 2007; 35: 1404-1410. Go to original source... Go to PubMed...
  37. Levi M. Disseminated intravascular coagulation. Crit Care Med 2007; 35: 2191-2195. Go to original source... Go to PubMed...
  38. Levi M, Opal SM. Coagulation abnormalities in critically ill patients. Crit Care 2006; 10: 222. Go to original source... Go to PubMed...
  39. Levi M, van der Poll T. Recombinant human activated protein C: current insights into its mechanism of action. Crit Care 2007; 11 (Suppl 5): S3. Go to original source... Go to PubMed...
  40. Levi M, van der Poll T. Inflammation and coagulation. Crit Care Med 2010; 38 (Suppl 2): S26-S34. Go to original source... Go to PubMed...
  41. Levy B. Bench-to-bedside review: Is there a place for epinephrine in septic shock? Crit Care 2005; 9: 561-565. Go to original source... Go to PubMed...
  42. Levy B. Lactate and shock state: the metabolic view. Curr Opin Crit Care 2006; 12: 315-321. Go to original source... Go to PubMed...
  43. Lortholary O, Lefort A, Tod M et al. Pharmacodynamics and pharmacokinetics of antibacterial drugs in the management of febrile neutropenia. Lancet Infect Dis 2008; 8: 612-620. Go to original source... Go to PubMed...
  44. Lundy DJ, Trzeciak S. Microcirculatory dysfunction in sepsis. Crit Care Clin 2009; 25: 721-731. Go to original source... Go to PubMed...
  45. Magder S. Bench-to-bedside review: ventilatory abnormalities in sepsis. Crit Care 2009; 13: 202. Go to original source... Go to PubMed...
  46. Marik PE, Pastores SM, Annane D et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 2008; 36: 1937-1949. Go to original source... Go to PubMed...
  47. Marik PE, Zaloga GP. Immunonutrition in critically ill patients: a systematic review and analysis of the literature. Intensive Care Med 2008; 34: 1980-1990. Go to original source... Go to PubMed...
  48. Marshall JC, Reinhart K. International Sepsis Forum. Biomarkers of sepsis. Crit Care Med 2009; 37: 2290-2298. Go to original source... Go to PubMed...
  49. Mendes AV, Sapolnik R, Mendonça N. New guidelines for the clinical management of febrile neutropenia and sepsis in pediatric oncology patients. J Pediatr 2007; 83 (Suppl 2): S54-S63. Go to original source... Go to PubMed...
  50. Napolitano LM, Kurek S, Luchette FA et al. Clinical practice guideline: red blood cell transfusion in adult trauma and critical care. Crit Care Med 2009; 37: 3124-3157. Go to original source... Go to PubMed...
  51. Nobre V, Sarasin FP, Pugin J. Prompt antibiotic administration and goal-directed hemodynamic support in patients with severe sepses and septic shock. Curr Opin Crit Care 2007; 13: 586-591. Go to original source... Go to PubMed...
  52. Opal SM, LaRosa SP. Year in review 2008: Critical Care - sepsis. Critical Care 2009; 13: 224. Go to original source... Go to PubMed...
  53. Ragaller M, Fritzsche K, Sengebusch K et al. Treatment of sepsis - what is indispensable? Anasthesiol Intensiv Med 2009; 50: 654.
  54. Roche AM, James MF. Colloids and crystalloids: does it matter to the kidney? Curr Opin Crit Care 2009; 15: 520-524. Go to original source... Go to PubMed...
  55. Rodloff AC, Goldstein EJ, Torres A. Two decades of imipenem therapy. J Antimicrob Chemother 2006; 58: 916-929. Go to original source... Go to PubMed...
  56. Rodríguez-Baño J. Selection of empiric therapy in patients with catheter-related infections. Clin Microbiol Infect 2002; 8: 275-281. Go to original source... Go to PubMed...
  57. Ronco C, Tetta C. Extracorporal blood purification: more than diffusion and convection. Does this help? Curr Opin Crit Care 2007; 13: 662-667. Go to original source... Go to PubMed...
  58. Rudiger A, Singer M. Mechanisms of sepsis-induced cardiac dysfunction. Crit Care Med 2007; 35: 1599-1608. Go to original source... Go to PubMed...
  59. Sandrock CE, Albertson TE. Controversies in the treatment of sepsis. Semin Respir Crit Care Med 2010; 31: 66-78. Go to original source... Go to PubMed...
  60. Sevransky J. Clinical assessment of hemodynamically unstable patients. Curr Opin Crit Care 2009; 15: 234-238. Go to original source... Go to PubMed...
  61. Sevransky JE, Nour S, Susla GM et al. Hemodynamic goals in randomized clinical trials in patients with sepsis: a systematic review of the literature. Crit Care 2007; 11: R67. Go to original source... Go to PubMed...
  62. Sharma AC. Sepsis-induced myocardial dysfunction. Shock 2007; 28: 265-269. Go to original source... Go to PubMed...
  63. Siami S, Annane D, Sharshar T. The encephalopathy in sepsis. Crit Care Clin 2008; 24: 67-82. Go to original source... Go to PubMed...
  64. Singer P, Shapiro H, Theilla M et al. Anti-inflammatory properties of omega-3 fatty acids in critical illness: novel mechanisms and an integrative perspective. Intensive Care Med 2008; 34: 1580-1592. Go to original source... Go to PubMed...
  65. Singh S, Evans TW. Organ dysfunction during sepsis. Intensive Care Med 2006; 32: 349-360. Go to original source... Go to PubMed...
  66. Stevens RD, Dowdy DW, Michaels RK et al. Neuromuscular dysfunction acquired in critical illness: a systematic review. Intensive Care Med 2007; 33: 1876-1891. Go to original source... Go to PubMed...
  67. Sutherland AM, Walley KR. Bench-to-bedside review: Association of genetic variation with sepsis. Crit Care 2009; 13: 210.
  68. Thirumala R, Ramaswamy M, Chawla S. Diagnosis and management of infectious complications in critically Ill patients with cancer. Crit Care Clin 2010; 26: 59-91. Go to original source... Go to PubMed...
  69. van Haren FM, Sleigh JW, Pickkers P et al. Gastrointestinal perfusion in septic shock. Anaesth Intensive Care 2007; 35: 679-694. Go to original source... Go to PubMed...
  70. Vriesendorp TM, DeVries JH, Hoekstra JB. Hypoglycemia and strict glycemic control in critically ill patients. Curr Opin Crit Care 2008; 14: 397-402. Go to original source... Go to PubMed...
  71. Westphal M, Van Aken H, Rehberg S et al. All colloids are not the same. Anasthesiol Intensiv Med 2009; 50: 378-381.
  72. Wiedermann CJ. Clinical review: molecular mechanisms underlying the role of antithrombin in sepsis. Crit Care 2006; 10: 209. Go to original source... Go to PubMed...
  73. Zarychanski R, Ariano RE, Paunovic B et al. Historical perspectives in critical care medicine: blood transfusion, intravenous fluids, inotropes/vasopressors, and antibiotics. Crit Care Clin 2009; 25: 201-220. Go to original source... Go to PubMed...
  74. Zimmerman JJ. A history of adjunctive glucocorticoid treatment for pediatric sepsis: moving beyond steroid pulp fiction toward evidence-based medicine. Pediatr Crit Care Med 2007; 8: 530-539. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.